Person Details

Katherine Kalin, MBA

Katherine Kalin, MBA , Elected 2020

Ms. Kalin has served as a Director since November 2020. Ms. Kalin has more than 25 years of experience as a senior executive in healthcare and professional services, most recently at Celgene Corporation, where she led corporate strategy from 2012 to 2017 and Johnson & Johnson, where she held leadership roles in marketing, sales and new business development from 2002 to 2011. Prior to that, she was a partner in the global healthcare practice of McKinsey & Company from 1990-2002. Her healthcare industry experience spans diagnostics, medical devices, pharmaceuticals and digital health. Ms. Kalin currently serves, since July 2020, as a non-executive director on the board of Genfit, S.A., a publicly traded French biopharmaceutical company and, since 2018, as a member of the board of directors of Brown Advisory LLC, an independent investment and strategic advisory firm and Clinical Genomics, a biotech dedicated to improving patient outcomes through early detection of colorectal cancer. She is also a member, since October 2020, of the Advisory Board of Stardog, an enterprise data company and, since 2018, of PRIMARI Analytics, an artificial intelligence startup. She has a B.A. from Durham University, U.K., and an M.B.A. from Harvard Business School.

Independent Director

Audit Committee

Compensation Committee